Log in

TSE:ARZ - Aralez Pharmaceuticals Stock Price, Forecast & News

Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average Volume79,103 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Aralez Pharmaceuticals Inc operates as a specialty pharmaceutical company in the United States and Canada. It engages in acquiring, developing, and commercializing products in the areas of cardiovascular, pain management, dermatological allergy, and other indications. It offers Zontivity for the reduction of thrombotic cardiovascular events in patients with heart attack or peripheral arterial disease; Toprol-XL, a cardioselective beta-blocker that is indicated for the treatment of hypertension; Fibricor, a fenofibric acid for the treatment of severe hypertriglyceridemia and patients with primary hypercholesterolemia or mixed dyslipidemia; and Blexten, an antihistamine drug for the symptomatic relief of allergic rhinitis and chronic spontaneous urticarial. Read More…

Industry, Sector and Symbol

Industry Gold
Sub-IndustryN/A
SectorBasic Materials
CUSIPN/A
CIKN/A
Phone+1-905-8761118

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive ARZ News and Ratings via Email

Sign-up to receive the latest news and ratings for ARZ and its competitors with MarketBeat's FREE daily newsletter.


Aralez Pharmaceuticals (TSE:ARZ) Frequently Asked Questions

What is Aralez Pharmaceuticals' stock symbol?

Aralez Pharmaceuticals trades on the Toronto Stock Exchange (TSX) under the ticker symbol "ARZ."

Has Aralez Pharmaceuticals been receiving favorable news coverage?

News headlines about ARZ stock have been trending negative recently, InfoTrie reports. The research group identifies negative and positive press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Aralez Pharmaceuticals earned a media sentiment score of -2.4 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View News Stories for Aralez Pharmaceuticals.

Who are some of Aralez Pharmaceuticals' key competitors?

What other stocks do shareholders of Aralez Pharmaceuticals own?

Who are Aralez Pharmaceuticals' key executives?

Aralez Pharmaceuticals' management team includes the folowing people:
  • Mr. Adrian Adams, CEO & Director (Age 67)
  • Mr. Andrew I. Koven, Pres & Chief Bus. Officer (Age 60)
  • Mr. Michael Kaseta, Chief Financial Officer (Age 42)
  • Dr. James Patrick Tursi, Chief Medical Officer (Age 53)
  • Mr. John E. Barnhardt CPA, Principal Accounting Officer and VP of Fin. & Admin. (Age 68)

How do I buy shares of Aralez Pharmaceuticals?

Shares of ARZ and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Aralez Pharmaceuticals' official website?

The official website for Aralez Pharmaceuticals is http://aralez.com/.

How can I contact Aralez Pharmaceuticals?

Aralez Pharmaceuticals' mailing address is 7100 West Credit Ave Suite 101, MISSISSAUGA, ON L5N 0E4, Canada. The company can be reached via phone at +1-905-8761118.


MarketBeat Community Rating for Aralez Pharmaceuticals (TSE ARZ)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  93 (Vote Outperform)
Underperform Votes:  119 (Vote Underperform)
Total Votes:  212
MarketBeat's community ratings are surveys of what our community members think about Aralez Pharmaceuticals and other stocks. Vote "Outperform" if you believe ARZ will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ARZ will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel